51 |
Sunovion Pharmaceuticals Inc. v. Watson Pharmaceuticals Inc. et al |
1:12-cv-00993 |
D.Del. |
|
|
|
|
52 |
PURDUE PHARMACEUTICAL PRODUCTS, L.P. et al |
2:12-cv-05390 |
D.N.J. |
|
|
|
|
53 |
PURDUE PHARMACEUTICAL PRODUCTS, L.P. et al |
2:12-cv-05390 |
D.N.J. |
|
|
|
|
54 |
PURDUE PHARMACEUTICAL PRODUCTS, L.P. et al |
2:12-cv-05390 |
D.N.J. |
|
|
|
|
55 |
Avanir Pharmaceuticals Inc. v. Watson Pharmaceuticals Inc. et al |
1:12-cv-01124 |
D.Del. |
|
|
|
|
56 |
Depomed Inc. v. Watson Laboratories Inc. - Florida et al |
1:13-cv-00342 |
D.Del. |
|
|
|
|
57 |
Sanofi et al v. Watson Laboratories Inc. |
1:14-cv-00265 |
D.Del. |
|
|
|
|
58 |
Sanofi et al v. Watson Laboratories Inc. |
1:14-cv-00265 |
D.Del. |
|
|
|
|
59 |
DOW PHARMACEUTICAL SCIENCES, INC. et al v. ACTAVIS, INC. et al |
2:14-cv-02661 |
D.N.J. |
|
|
|
|
60 |
DOW PHARMACEUTICAL SCIENCES, INC. et al v. ACTAVIS, INC. et al |
2:14-cv-02661 |
D.N.J. |
|
|
|
|
61 |
CELGENE CORPORATION v. NATCO PHARMA LIMITED et al |
2:14-cv-03126 |
D.N.J. |
|
|
|
|